lang select icon



home icon   kontakt icon   sitemap icon
header about us

About us

Established in April 2003, BIONIME is specialized in biotechnology and medical device business. Self Monitoring Blood Glucose System (SMBG) for home use as well as devices and software solutions for Point of Care Testing (POCT) and IOT solutions are in BIONIME’s product portfolio. BIONIME integrates the top-tier expertise in medical science, chemistry, electronics and precision mechanism to commercialize the patent protected unique test strip technology.

BIONIME employs more than 900 employees and operates five subsidiaries in major markets, Europe, America and Asia. The products have been highly recognized by outstanding clinical tests and well-known journals internationally and successfully distributed into the worldwide markets.

vision thumbWith our „peace of mind“ medical devices we offer solutions to patients to accurately manage and control their own health ...
philosophy thumb It is Bionime’s philosophy to make the “best product” available for home use and to become a reliable and caring partner to monitor diabetes in everyday life ...
 
milestones thumb BIONIME together with qualified experts in the field of diabetes have initiated and completed several SMBG patents during the last few years ...
Investor Relation Here you can find Bionime´s Company Profile, Finacial Informations, News, Stock Informations and many more...
gm700 video
gm100 instruction
gm300 instruction
gm550 instruction